Company profile for CIPHER PHARMS INC

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a specialty pharmaceutical company that develops improved formulations of existing drugs. We search for products in defined markets to in-license into our pipeline. These products are based on currently marketed molecules paired with a novel drug delivery technology for enhanced performance. Our core competency is identifying these product opportunities and managing their clinical and regulatory development. Finally, we...
We are a specialty pharmaceutical company that develops improved formulations of existing drugs. We search for products in defined markets to in-license into our pipeline. These products are based on currently marketed molecules paired with a novel drug delivery technology for enhanced performance. Our core competency is identifying these product opportunities and managing their clinical and regulatory development. Finally, we harvest the rewards by out-licensing to partners and generating royalty streams.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
5650 Tomken Rd.
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://cipher.investorroom.com/2021-02-10-Cipher-Pharmaceuticals-Enters-into-Co-Promotion-Agreement-with-Verity-Pharmaceuticals-Inc#:~:text=OAKVILLE%2C%20ON%2C%20Feb.%2010,of%20Brinavess%2C%20Aggrastat%20and%20Trevyent.

INVESTORROOM
10 Feb 2021

https://cipher.investorroom.com/2021-02-10-Cipher-Pharmaceuticals-Enters-into-Co-Promotion-Agreement-with-Verity-Pharmaceuticals-Inc#:~:text=OAKVILLE%2C%20ON%2C%20Feb.%2010,of%20Brinavess%2C%20Aggrastat%20and%20Trevyent.

INVESTORROOM
10 Feb 2021

https://www.biospace.com/article/releases/cipher-pharmaceuticals-receives-health-canada-approval-for-trulance-and-174-plecanatide-/?s=95

BIOSPACE
19 Oct 2019

https://www.raps.org/news-and-articles/news-articles/2018/7/arog-lands-opdp-untitled-letter-over-promotional-s?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2011%20July%202018

Michael Mezher RAPS
11 Jul 2018

https://www.prnewswire.com/news-releases/correvio-pharma-corp-completes-strategic-transaction-with-cipher-pharmaceuticals-300648550.html

PR NEWSWIRE
15 May 2018

https://www.prnewswire.com/news-releases/cipher-pharmaceuticals-and-cardiome-pharma-announce-strategic-transaction-for-canadian-business-portfolio-of-cardiome-677363803.html

PR NEWSWIRE
15 Apr 2018

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty